Huakang Pharmaceutical was founded in 1990, with the registered capital of RMB 173.14 million yuan. CCHT holds 47.75% of its shares and CCHT is the largest shareholder of ‘‘Huakang Pharmaceutical’’.
‘‘Huakang Pharmaceutical’’ is one of the top 50 enterprises in Chinese medicine industry, one of the most important demonstration enterprises of the national modern science and technology industry base, one of the national key high-tech enterprises and one of the national contract-observing and trustworthy enterprises. It has built up the national post-doctoral scientific research work station. Its leading products include Xueshuan Xinmaining Tablet, Yinhua Miyanling Tablet, Shuqing Granule and Weining Granule, etc.